Skip Nav Destination
Issues
1 February 1999
ISSN 1078-0432
EISSN 1557-3265
Review
Advances in Brief
Clinical Trials
Phase I Study of Escalating Doses of Edatrexate in Combination with Paclitaxel in Patients with Metastatic Breast Cancer
Gabriella D’Andrea; David Fennelly; Larry Norton; Jose Baselga; Teresa Gilewski; Clifford Hudis; Mary Ellen Moynahan; George Raptis; Nancy Sklarin; Antonella Surbone; Maria Theodoulou; Mary Agnes Templeton; Tzy-Jyun Yao; Andrew D. Seidman
Phase I Study of Eniluracil, a Dihydropyrimidine Dehydrogenase Inactivator, and Oral 5-Fluorouracil with Radiation Therapy in Patients with Recurrent or Advanced Head and Neck Cancer1
Rod A. Humerickhouse; M. Eileen Dolan; Daniel J. Haraf; Bruce Brockstein; Kerstin Stenson; Merrill Kies; Laura Sulzen; Mark J. Ratain; Everett E. Vokes
A Phase I and Pharmacokinetic Study of Losoxantrone and Paclitaxel in Patients with Advanced Solid Tumors1
Sami G. Diab; Sharyn D. Baker; Amita Joshi; Howard A. Burris; Patrick W. Cobb; Miguel A. Villalona-Calero; S. Gail Eckhardt; Geoffrey R. Weiss; Gladys I. Rodriguez; Ronald Drengler; Maura Kraynak; Lisa Hammond; Michael Finizio; Daniel D. Von Hoff; Eric K. Rowinsky
Absorption, Metabolism, and Excretion of 14C-Temozolomide following Oral Administration to Patients with Advanced Cancer1
Sharyn D. Baker; Mark Wirth; Paul Statkevich; Pascale Reidenberg; Kevin Alton; Susan E. Sartorius; Margaret Dugan; David Cutler; Vijay Batra; Louise B. Grochow; Ross C. Donehower; Eric K. Rowinsky
Molecular Oncology, Markers, Clinical Correlates
Experimental Therapeutics
In Vivo Localization of [111In]-DTPA-d-Phe1-Octreotide to Human Ovarian Tumor Xenografts Induced to Express the Somatostatin Receptor Subtype 2 Using an Adenoviral Vector1
Buck E. Rogers; Stephanie F. McLean; Richard L. Kirkman; Debbie Della Manna; Sheila J. Bright; Christine C. Olsen; Angela D. Myracle; Matthew S. Mayo; David T. Curiel; Donald J. Buchsbaum
Presentation of Renal Tumor Antigens by Human Dendritic Cells Activates Tumor-infiltrating Lymphocytes against Autologous Tumor: Implications for Live Kidney Cancer Vaccines1
Peter Mulders; Cho-Lea Tso; Barbara Gitlitz; Randhir Kaboo; Andreas Hinkel; Stacey Frand; Sylvia Kiertscher; Michael D. Roth; Jean deKernion; Robert Figlin; Arie Belldegrun
Cancer Biology, Immunology, Cytokines
Meeting Report
Letters to the Editor
Errata
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.